ArticleVaccines2022

Neutralizing Antibody Response, Safety, and Efficacy of mRNA COVID-19 Vaccines in Pediatric Patients with Inflammatory Bowel Disease: A Prospective Multicenter Case-Control Study.

Kyung Jae Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.